<unk>  is indicated in the treatment of type-2 diabetes mellitus: * it is indicated in the treatment of adults who are unable to achieve sufficient glycaemic control at their maximally tolerated dose of oral metformin alone or who are already treated with the combination of<unk>  and metformin as separate tablets. * it is indicated in combination with a sulphonylurea (i.e. triple combination therapy) as an adjunct to diet and exercise in patients inadequately controlled with metformin and a sulphonylurea. * it is indicated in triple combination therapy with insulin as an adjunct to diet and exercise to improve glycaemic control in patients when insulin at a stable dose and metformin alone do not provide adequate glycaemic control.
Vildagliptin/metformin
Glibenclamide/metformin
Pioglitazone/metformin
Sitagliptin/metformin
Insulin degludec/liraglutide
Canagliflozin/metformin
Empagliflozin/metformin
Dapagliflozin/saxagliptin/metformin